| Product NDC: | 49349-337 |
| Proprietary Name: | CYMBALTA |
| Non Proprietary Name: | CYMBALTA |
| Active Ingredient(s): | 60 mg/1 & nbsp; CYMBALTA |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 49349-337 |
| Labeler Name: | REMEDYREPACK INC. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021427 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101223 |
| Package NDC: | 49349-337-02 |
| Package Description: | 30 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (49349-337-02) |
| NDC Code | 49349-337-02 |
| Proprietary Name | CYMBALTA |
| Package Description | 30 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (49349-337-02) |
| Product NDC | 49349-337 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CYMBALTA |
| Dosage Form Name | CAPSULE, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20101223 |
| Marketing Category Name | NDA |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | DULOXETINE HYDROCHLORIDE |
| Strength Number | 60 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |